Roth Capital Has Pessimistic Outlook of Nuwellis Q1 Earnings

Nuwellis, Inc. (NASDAQ:NUWEFree Report) – Roth Capital dropped their Q1 2025 earnings estimates for Nuwellis in a report released on Tuesday, March 11th. Roth Capital analyst J. Aschoff now anticipates that the company will post earnings per share of ($0.45) for the quarter, down from their prior estimate of ($0.30). The consensus estimate for Nuwellis’ current full-year earnings is ($8.17) per share. Roth Capital also issued estimates for Nuwellis’ Q2 2025 earnings at ($0.36) EPS, Q3 2025 earnings at ($0.35) EPS, Q4 2025 earnings at ($0.28) EPS, FY2025 earnings at ($1.39) EPS, FY2026 earnings at ($0.52) EPS, FY2027 earnings at $0.09 EPS, FY2028 earnings at $0.78 EPS and FY2029 earnings at $1.41 EPS.

Nuwellis Price Performance

Shares of NUWE opened at $1.15 on Thursday. The firm has a market capitalization of $5.03 million, a PE ratio of -0.01 and a beta of 0.36. The company’s fifty day moving average price is $1.22 and its 200-day moving average price is $1.34. Nuwellis has a 1-year low of $0.92 and a 1-year high of $16.63.

Institutional Trading of Nuwellis

An institutional investor recently bought a new position in Nuwellis stock. Geode Capital Management LLC bought a new position in shares of Nuwellis, Inc. (NASDAQ:NUWEFree Report) in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund bought 30,806 shares of the company’s stock, valued at approximately $34,000. Geode Capital Management LLC owned 0.70% of Nuwellis as of its most recent SEC filing. Institutional investors own 3.13% of the company’s stock.

About Nuwellis

(Get Free Report)

Nuwellis, Inc, a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company offers Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure. Its Aquadex FlexFlow system includes a console, disposable blood circuit set, and disposable catheter.

Further Reading

Earnings History and Estimates for Nuwellis (NASDAQ:NUWE)

Receive News & Ratings for Nuwellis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nuwellis and related companies with MarketBeat.com's FREE daily email newsletter.